Premium
SPECIFIC INHIBITION BY SOMATOSTATIN OF GROWTH HORMONE RELEASE AFTER HYPOGLYCAEMIA IN NORMAL MAN
Author(s) -
COPINSCHI G.,
VIRASORO E.,
VANHAELST L.,
LECLERCQ R.,
GOLSTEIN J.,
L'HERMITE M.
Publication year - 1974
Publication title -
clinical endocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.055
H-Index - 147
eISSN - 1365-2265
pISSN - 0300-0664
DOI - 10.1111/j.1365-2265.1974.tb02815.x
Subject(s) - somatostatin , endocrinology , medicine , prolactin , growth hormone , hormone , insulin , chemistry
In normal man, synthetic linear somatostatin (growth hormone‐release inhibiting hormone) inhibits the growth hormone response to insulin induced hypoglycaemia, but has no influence on plasma levels of cortisol, prolactin, TSH and FSH.